Narayana Health has reported its financial performance for the year ended March 31, 2026, showcasing robust growth. The Board of Directors has recommended a final dividend of ₹4.50 per share. Additionally, the company announced the re-appointment of Ms. Terri Smith Bresenham as an Independent Director and secured approval to raise up to ₹1,500 crores through debt securities for future expansion. The company’s 26th Annual General Meeting is scheduled for August 14, 2026.
Strong Financial Performance
For the financial year ended March 31, 2026, Narayana Health achieved significant operational milestones. The company recorded a consolidated revenue of ₹78,960.35 million, marking a substantial increase from the previous year. The net profit after tax for the same period stood at ₹8,055.99 million, reflecting the company’s strong operational efficiency and market position in the healthcare sector.
Dividend and Shareholder Benefits
Demonstrating a commitment to value creation, the Board of Directors has recommended a final dividend of ₹4.50 per share for the financial year 2025-26. Shareholders should note that the company has fixed July 17, 2026, as the record date to determine eligibility for this dividend payout. The proposal is subject to approval by shareholders at the upcoming 26th Annual General Meeting, which will be held virtually on August 14, 2026.
Strategic Growth and Capital Raising
To support its long-term strategic objectives, the Board has received authorization to issue debt securities, including Non-Convertible Debentures (NCDs), up to a limit of ₹1,500 crores in a financial year. These funds will be utilized to drive future growth and enhance service infrastructure. Furthermore, the company continues its focus on leadership excellence with the re-appointment of Ms. Terri Smith Bresenham as an Independent Director for a second five-year term ending on August 4, 2031, ensuring continuity in governance and strategic oversight.
Source: BSE
